RLAY
Price
$3.59
Change
+$0.04 (+1.13%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
615.49M
35 days until earnings call
TERN
Price
$4.53
Change
+$0.53 (+13.25%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
395.64M
34 days until earnings call
Interact to see
Advertisement

RLAY vs TERN

Header iconRLAY vs TERN Comparison
Open Charts RLAY vs TERNBanner chart's image
Relay Therapeutics
Price$3.59
Change+$0.04 (+1.13%)
Volume$13.39K
Capitalization615.49M
Terns Pharmaceuticals
Price$4.53
Change+$0.53 (+13.25%)
Volume$19.65K
Capitalization395.64M
RLAY vs TERN Comparison Chart in %
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. TERN commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Buy and TERN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (RLAY: $3.59 vs. TERN: $4.53)
Brand notoriety: RLAY and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 53% vs. TERN: 176%
Market capitalization -- RLAY: $615.49M vs. TERN: $395.64M
RLAY [@Biotechnology] is valued at $615.49M. TERN’s [@Biotechnology] market capitalization is $395.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 3 bearish.
  • TERN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than TERN.

Price Growth

RLAY (@Biotechnology) experienced а +1.99% price change this week, while TERN (@Biotechnology) price change was +17.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

RLAY is expected to report earnings on Nov 05, 2025.

TERN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($615M) has a higher market cap than TERN($396M). RLAY YTD gains are higher at: -13.835 vs. TERN (-27.798). TERN has higher annual earnings (EBITDA): -103.02M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. TERN (334M). TERN has less debt than RLAY: TERN (1.24M) vs RLAY (47.2M). RLAY has higher revenues than TERN: RLAY (7.68M) vs TERN (0).
RLAYTERNRLAY / TERN
Capitalization615M396M155%
EBITDA-373.07M-103.02M362%
Gain YTD-13.835-27.79850%
P/E RatioN/AN/A-
Revenue7.68M0-
Total Cash710M334M213%
Total Debt47.2M1.24M3,822%
TECHNICAL ANALYSIS
Technical Analysis
RLAYTERN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDXXF0.07N/A
+1.39%
PharmAla Biotech Holdings Inc.
DBSDY143.131.77
+1.25%
DBS Group Holdings Ltd.
CGGGF1.06N/A
N/A
Coats Group PLC
MPIR0.02N/A
N/A
Empire Diversified Energy, Inc.
WHGLY19.21-0.29
-1.49%
WH Group Ltd.

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-1.39%
XNCR - RLAY
52%
Loosely correlated
-5.70%
BCYC - RLAY
50%
Loosely correlated
-3.50%
IMNM - RLAY
49%
Loosely correlated
-1.70%
BDTX - RLAY
48%
Loosely correlated
-3.10%
RXRX - RLAY
47%
Loosely correlated
-6.45%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with SYRE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-7.41%
SYRE - TERN
50%
Loosely correlated
-2.92%
BEAM - TERN
49%
Loosely correlated
-4.15%
VRDN - TERN
47%
Loosely correlated
+1.40%
NKTX - TERN
47%
Loosely correlated
-3.43%
IDYA - TERN
46%
Loosely correlated
-4.25%
More